Literature DB >> 25552305

Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer.

Elizabeth Tran1, Clayton Spiceland1, Nicole P Sandhu1, Aminah Jatoi2.   

Abstract

We sought to report incidence, risk factors, and survival related to bowel obstruction in 311 ovarian cancer patients with recurrent disease. A total of 68 (22%) had a documented bowel obstruction during their cancer course, and 49 (16%) developed it after cancer recurrence. Surprisingly, 142 (45%) fit into an "unknown" category (3+ months of data lacking from last contact/death). No risk factors were identified; management included surgery (n = 21), conservative measures (n = 21), and other (n = 7). Documented bowel obstruction was not associated with a statistically significant reduction in survival after cancer recurrence. In conclusion, although bowel obstruction occurs in only a subgroup of patients with ovarian cancer and does not appear to detract from survival after cancer recurrence, limited end-of-life information may be resulting in an underestimation of incidence.
© The Author(s) 2014.

Entities:  

Keywords:  bowel obstruction; end of life; morbidity; ovarian cancer

Mesh:

Year:  2014        PMID: 25552305      PMCID: PMC4569524          DOI: 10.1177/1049909114566225

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  5 in total

1.  Bowel obstruction and survival in patients with advanced ovarian cancer: analysis of prognostic variables.

Authors:  Enrico Sartori; Francesca Chiudinelli; Brunella Pasinetti; Tiziano Maggino
Journal:  Int J Gynecol Cancer       Date:  2009-01       Impact factor: 3.437

Review 2.  Ovarian cancer.

Authors:  Gordon C Jayson; Elise C Kohn; Henry C Kitchener; Jonathan A Ledermann
Journal:  Lancet       Date:  2014-04-21       Impact factor: 79.321

3.  Failure of second-look laparotomy to influence survival in epithelial ovarian cancer.

Authors:  D Luesley; F Lawton; G Blackledge; C Hilton; K Kelly; T Rollason; T Wade-Evans; J Jordan; J Fielding; T Latief
Journal:  Lancet       Date:  1988-09-10       Impact factor: 79.321

4.  Bowel obstruction in elderly ovarian cancer patients: a population-based study.

Authors:  Stephen J Mooney; Megan Winner; Dawn L Hershman; Jason D Wright; Daniel L Feingold; John D Allendorf; Alfred I Neugut
Journal:  Gynecol Oncol       Date:  2012-12-26       Impact factor: 5.482

Review 5.  Palliative surgery versus medical management for bowel obstruction in ovarian cancer.

Authors:  Ali Kucukmetin; Raj Naik; Khadra Galaal; Andrew Bryant; Heather O Dickinson
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07
  5 in total
  7 in total

1.  Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases.

Authors:  Kaitlin C Fogg; Carine M Renner; Hannah Christian; Alyssa Walker; Leilani Marty-Santos; Aisha Khan; Will R Olson; Carl Parent; Andrea O'Shea; Deneen M Wellik; Paul S Weisman; Pamela K Kreeger
Journal:  Tissue Eng Part A       Date:  2020-06-25       Impact factor: 3.845

2.  Surgical and Conservative Management of Malignant Bowel Obstruction: Outcome and Prognostic Factors.

Authors:  Kaiying Yu; Lihui Liu; Xiaowei Zhang; Zhanzhi Zhang; Benqiang Rao; Yongbing Chen; Suyun Li; Hanping Shi
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

3.  Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway.

Authors:  Kaitlin C Fogg; Will R Olson; Jamison N Miller; Aisha Khan; Carine Renner; Isaac Hale; Paul S Weisman; Pamela K Kreeger
Journal:  Cancer Lett       Date:  2019-05-24       Impact factor: 8.679

Review 4.  Malignant Bowel Obstruction in Advanced Gynecologic Cancers: An Updated Review from a Multidisciplinary Perspective.

Authors:  Yeh Chen Lee; Nazlin Jivraj; Catherine O'Brien; Tanya Chawla; Eran Shlomovitz; Sarah Buchanan; Jenny Lau; Jennifer Croke; Johane P Allard; Preeti Dhar; Stephane Laframboise; Sarah E Ferguson; Neesha Dhani; Marcus Butler; Pamela Ng; Terri Stuart-McEwan; Pamela Savage; Lisa Tinker; Amit M Oza; Stephanie Lheureux
Journal:  Obstet Gynecol Int       Date:  2018-05-17

5.  PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.

Authors:  Cristian Rodriguez-Aguayo; Emine Bayraktar; Cristina Ivan; Burcu Aslan; Junhua Mai; Guangan He; Lingegowda S Mangala; Dahai Jiang; Archana S Nagaraja; Bulent Ozpolat; Arturo Chavez-Reyes; Mauro Ferrari; Rahul Mitra; Zahid H Siddik; Haifa Shen; Xianbin Yang; Anil K Sood; Gabriel Lopez-Berestein
Journal:  EBioMedicine       Date:  2019-01-14       Impact factor: 11.205

6.  Optimizing the Care of Malignant Bowel Obstruction in Patients With Advanced Gynecologic Cancer.

Authors:  Yeh Chen Lee; Nazlin Jivraj; Lisa Wang; Tanya Chawla; Jenny Lau; Jennifer Croke; Johane P Allard; Terri Stuart-McEwan; Kashish Nathwani; Valerie Bowering; Katherine Karakasis; Catherine O'Brien; Eran Shlomovitz; Sarah E Ferguson; Sarah Buchanan; Pamela Ng; Sunu Cyriac; Lisa Tinker; Neesha Dhani; Amit M Oza; Stephanie Lheureux
Journal:  J Oncol Pract       Date:  2019-09-24       Impact factor: 3.840

7.  Surgical intervention for malignant bowel obstruction caused by gastrointestinal malignancies.

Authors:  Peng-Ju Chen; Lin Wang; Yi-Fan Peng; Nan Chen; Ai-Wen Wu
Journal:  World J Gastrointest Oncol       Date:  2020-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.